Sonio

Sonio is a highly verified medical technology company specializing in AI-based prenatal screening. The company has achieved exceptional real-world traction, evidenced by its acquisition by Samsung Medison for approximately $92.7M (validated against the user's 'marketcap' claim) and FDA 510(k) clearance for its Sonio Detect software. While the project submission form itself contained low-quality or inaccurate text (e.g., claiming 'everyone' as the audience and 'most people' as users), the external verification confirms this is a high-utility, technically innovative, and commercially successful project. The score reflects the massive verified success (Exit/FDA) while penalizing the poor response quality.